Published Online
on July 20, 2006

A more recent version of this article appeared on September 1, 2006

This Article Full Text (PDF) All Versions of this Article: 37/9/2428    most recent 01.STR.0000236037.87109.fcv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Norris, J. W. Articles by Barnett, H. J. Search for Related Content PubMed PubMed Citation Articles by Norris, J. W. Articles by Barnett, H. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Thinners Related Collections Antiplatelets

Submitted on June 28, 2006
Accepted on June 29, 2006

CHARISMA. The Antiplatelet Saga Continues

John W. Norris MD^* and Henry J. Barnett MD, CC

From the St Georges Medical School (J.W.N.), University of London, UK; and the Robarts Research Institute (H.J.B.), London, Ontario, Canada.

^* To whom correspondence should be addressed. E-mail: carotid{at}btopenworld.com.

Key words: antiplatelet agents • antiplatelet drugs • clinical trials

This article has been cited by other articles:

				S. Sacco and A. Carolei CHARISMA: The Antiplatelet Saga Continues Stroke, March 1, 2007; 38(3): 854 - 854. [Full Text] [PDF]